» Articles » PMID: 23858328

Neuroradiological Evaluation of Demyelinating Disease

Overview
Specialty Neurology
Date 2013 Jul 17
PMID 23858328
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.

Citing Articles

Role of Magnetic Resonance Imaging in evaluating T2-weighted hyperintensities in spinal cord in a tertiary care hospital in central India.

Dhabalia R, Kashikar S F1000Res. 2025; 13:502.

PMID: 39989483 PMC: 11844792. DOI: 10.12688/f1000research.144117.3.


The canine blood-brain barrier in health and disease: focus on brain protection.

Bassalo D, Matthews S, Bloise E Vet Q. 2025; 45(1):12-32.

PMID: 39791202 PMC: 11727060. DOI: 10.1080/01652176.2025.2450041.


The research trend on neurobrucellosis over the past 30 years (1993-2023): a bibliometric and visualization analysis.

Yang L, Pan W, Cai Q, An M, Wang C, Pan X Front Neurol. 2024; 15:1349530.

PMID: 39381075 PMC: 11460295. DOI: 10.3389/fneur.2024.1349530.


A Study of the Role of Magnetic Resonance Imaging in the Evaluation of T2-Weighted Hyperintensities in Spinal Cord in a Tertiary Care Hospital in Central India.

Dhabalia R, Kashikar S, Parihar P, Nunna B, Bothara S, Reddy L Cureus. 2024; 16(8):e68197.

PMID: 39347239 PMC: 11439468. DOI: 10.7759/cureus.68197.


Acute disseminated encephalomyelitis in a young patient: A case report.

Codreanu-Balaban R, Stuparu A, Musat D, Baz R, Baz R, Docu-Axelerad S Exp Ther Med. 2024; 28(2):323.

PMID: 38939178 PMC: 11208760. DOI: 10.3892/etm.2024.12612.


References
1.
van Walderveen M, Lycklama A Nijeholt G, Ader H, Jongen P, Polman C, Castelijns J . Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol. 2001; 58(1):76-81. DOI: 10.1001/archneur.58.1.76. View

2.
Morrissey S, Miller D, Kendall B, KINGSLEY D, Kelly M, Francis D . The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. 1993; 116 ( Pt 1):135-46. DOI: 10.1093/brain/116.1.135. View

3.
Jasperse B, Valsasina P, Neacsu V, Knol D, De Stefano N, Enzinger C . Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX. J Magn Reson Imaging. 2007; 26(4):881-5. DOI: 10.1002/jmri.21101. View

4.
Banwell B, Bar-Or A, Arnold D, Sadovnick D, Narayanan S, McGowan M . Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011; 10(5):436-45. DOI: 10.1016/S1474-4422(11)70045-X. View

5.
Levesque I, Sled J, Narayanan S, Santos A, Brass S, Francis S . The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study. J Magn Reson Imaging. 2005; 21(2):103-10. DOI: 10.1002/jmri.20231. View